Visual Cell Sorting via Photoactivatable Markers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for high-content imaging and in situ sequencing are limited by the need for specialized hardware, complex protocols, and expensive reagents, which restrict their throughput and specificity for cell sorting and phenotypic analysis.

Innovation Solution

The development of Visual Cell Sorting, a method that uses a photo-activatable detectable marker, such as Dendra2, to image cells, determine phenotype status, and selectively activate the marker for subsequent sorting using fluorescence-activated cell sorting (FACS).

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If in situ sequencing methods are used to assess hundreds of perturbations in pooled format, then throughput and multiplexing capability are improved, but device complexity and protocol complexity increase due to specialized hardware and sophisticated computational pipelines

Engineering Contradiction:
ImprovethroughputVSAvoiddevice complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent extracts the sequencing function from complex in situ sequencing hardware and replaces it with a simpler photoactivatable protein marker system. Cells are imaged using standard microscopy, phenotypes are determined computationally, and matching cells are sorted using FACS based on photoactivatable marker activation. This separates the phenotyping function from the sorting function, eliminating the need for specialized sequencing hardware while maintaining high throughput.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses photoactivatable protein markers as optical copies or proxies for genetic barcodes. Instead of directly sequencing nucleic acid barcodes in each cell, the system activates fluorescent proteins in cells with desired phenotypes, creating an optical signature that can be detected by standard flow cytometry. This copying approach simplifies the hardware requirements while preserving the ability to sort hundreds of cell populations simultaneously.

Inventive Principle:
Principle #26Copying

2Measurement precision

If in situ sequencing with dye-based reagents is used, then sequencing accuracy is improved, but cost increases due to expensive reagents

Engineering Contradiction:
Improvesequencing accuracyVSAvoidcost
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent replaces expensive dye-based sequencing reagents with inexpensive photoactivatable protein markers. The fluorescent proteins (e.g., Dendra2, mEos3.2) can be expressed endogenously in cells and activated with standard UV or blue light. This substitution dramatically reduces per-cell costs while maintaining the ability to accurately identify and sort cells based on their phenotypic characteristics.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of operation

If photoactivatable markers are used for cell sorting, then ease of operation is improved, but throughput is limited compared to high-content imaging methods

Engineering Contradiction:
Improveease of operationVSAvoidthroughput
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent merges image-based phenotyping with flow cytometry-based sorting into a unified system. Standard microscopy images are used to determine cell phenotypes, and the same photoactivatable markers that serve as phenotypic indicators are also used as sorting signals in FACS. This integration allows the system to process hundreds of thousands of cells per hour while maintaining simple operation using commercially available instruments.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent performs preliminary phenotyping of all cells in the population using standard imaging before sorting. Cells are imaged, phenotypes are determined computationally, and then only the matching cells are sorted based on their photoactivatable marker activation status. This preliminary classification step enables the system to handle large cell populations efficiently by pre-identifying which cells require sorting.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Visual Cell Sorting enables high-throughput cell sorting and phenotypic analysis, allowing for the separation of hundreds of thousands of cells based on visual phenotypes and facilitating pooled genetic screening and transcriptomic profiling without the need for expensive reagents or specialized hardware.

Implementation Method 1

exposing the individual cells exhibiting a desired phenotype status for the one or more phenotypes to a light wavelength for a time sufficient to uniquely activate the photo-activatable detectable marker

Methodology Applied
Scientific EffectPhoto-activation: Photochromism

Data Source

PatentUS12298297B2Visual cell sorting
Publication Date: 2025.05.13 UNIV OF WASHINGTON
  • US12298297B2 patent drawing
  • US12298297B2 patent drawing
  • US12298297B2 patent drawing

AI summary

The disclosure provides methods, systems and related software, for automated or semi-automated sorting and/or isolating cells with visually distinguishable phenotypes. In some embodiments, the methods comprise providing a plurality cells with a photo-activatable detectable marker in their respective nuclei. The plurality of cells are imaged and, based on the image, the status for one or more visually identifiable phenotypes are determined. Cells determined to have the desired phenotype status are specifically exposed to a light wavelength for a time sufficient to uniquely activate the photo-activatable detectable marker in the individual cells with the desired phenotype status. The cells are then sorted on the basis of the activated detectable marker. The disclosure also provides methods for preparation and isolation of nuclei from fixed, adherent cells for analysis.